| Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 10949 | 2021 |
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study KL Kotloff, JP Nataro, WC Blackwelder, D Nasrin, TH Farag, ... The lancet 382 (9888), 209-222, 2013 | 3914 | 2013 |
| Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease … C Troeger, BF Blacker, IA Khalil, PC Rao, S Cao, SRM Zimsen, ... The Lancet Infectious Diseases 18 (11), 1211-1228, 2018 | 2584* | 2018 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review … T Shi, DA McAllister, KL O'Brien, EAF Simoes, SA Madhi, BD Gessner, ... The Lancet 390 (10098), 946-958, 2017 | 2310 | 2017 |
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. KL Kotloff, JP Winickoff, B Ivanoff, JD Clemens, DL Swerdlow, ... Bulletin of the World Health Organization 77 (8), 651, 1999 | 1840 | 1999 |
| The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children RB Belshe, PM Mendelman, J Treanor, J King, WC Gruber, P Piedra, ... New England Journal of Medicine 338 (20), 1405-1412, 1998 | 1204 | 1998 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 1047 | 2022 |
| A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium W Checkley, AC White, D Jaganath, MJ Arrowood, RM Chalmers, ... The Lancet Infectious Diseases 15 (1), 85-94, 2015 | 976 | 2015 |
| 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea AL Shane, RK Mody, JA Crump, PI Tarr, TS Steiner, K Kotloff, JM Langley, ... Clinical Infectious Diseases 65 (12), e45-e80, 2017 | 862 | 2017 |
| Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study J Liu, JA Platts-Mills, J Juma, F Kabir, J Nkeze, C Okoi, DJ Operario, ... The Lancet 388 (10051), 1291-1301, 2016 | 848 | 2016 |
| A Multicentre Study of Shigella Diarrhoea in Six Asian Countries: Disease Burden, Clinical Manifestations, and Microbiology L Von Seidlein, DR Kim, M Ali, H Lee, XY Wang, VD Thiem, DG Canh, ... PLoS medicine 3 (9), e353, 2006 | 610 | 2006 |
| Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study KL O'Brien, HC Baggett, WA Brooks, DR Feikin, LL Hammitt, MM Higdon, ... The Lancet 394 (10200), 757-779, 2019 | 583 | 2019 |
| Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016 IA Khalil, C Troeger, BF Blacker, PC Rao, A Brown, DE Atherly, TG Brewer, ... The Lancet infectious diseases 18 (11), 1229-1240, 2018 | 561 | 2018 |
| Shigellosis KL Kotloff, MS Riddle, JA Platts-Mills, P Pavlinac, AKM Zaidi The Lancet 391 (10122), 801-812, 2018 | 543 | 2018 |
| Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine RB Belshe, WC Gruber, PM Mendelman, I Cho, K Reisinger, SL Block, ... The Journal of pediatrics 136 (2), 168-175, 2000 | 538 | 2000 |
| Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine RB Belshe, WC Gruber, PM Mendelman, HB Mehta, K Mahmood, ... The Journal of infectious diseases 181 (3), 1133-1137, 2000 | 487 | 2000 |
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road MM Levine, KL Kotloff, EM Barry, MF Pasetti, MB Sztein Nature Reviews Microbiology 5 (7), 540-553, 2007 | 422 | 2007 |
| Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico LM Dunkle, KL Kotloff, CL Gay, G Áñez, JM Adelglass, ... New England Journal of Medicine 386 (6), 531-543, 2022 | 414 | 2022 |
| Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults P Michetti, C Kreiss, KL Kotloff, N Porta, JL Blanco, D Bachmann, ... Gastroenterology 116 (4), 804-812, 1999 | 410 | 1999 |
| Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study IA Khalil, C Troeger, PC Rao, BF Blacker, A Brown, TG Brewer, ... The Lancet Global Health 6 (7), e758-e768, 2018 | 400 | 2018 |
